Clinical trial registry record

Geriatric and Quality of Life Assessments in Older Patients With Non-metastatic or Metastatic Head and Neck or Lung Cancer Undergoing Surgery or Chemoradiation and Their Caregivers

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated February 24, 2023.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT03902535
Last registry update
February 24, 2023
Status
Completed
Phase
Phase not reported
Sponsor
City of Hope Medical Center
Enrollment
28
Countries
United States
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
OBSERVATIONAL
Evidence population
Human clinical study registration
Participants
28
Population
ALL · 21 Years
Duration
2019-03-08 to 2022-06-17
Intervention
Comprehensive Geriatric Assessment; Quality-of-Life Assessment; Questionnaire Administration
Comparator
Not reported
Outcomes measured
Comprehensive geriatric assessment (CGA) scores and domains — Up to 6 months post therapy; Physical activity levels — Up to 6 months post therapy; Quality of life (QOL) measures — Up to 6 months post therapy; Incidence and type of grade 2-5 toxicities — Up to week 4; Family caregiver (FCG)-reported caregiving burden level and QOL scores — Up to 6 months post therapy; Percentage of patients with vulnerability using the geriatric assessment — Up to 6 months post therapy; Percentage of patients who receive and accept referrals — Up to 6 months post therapy; Treatment modification and healthcare utilization in patients — Up to week 12; Change in CGA scores and domains — Baseline up to 6 months post therapy; Change in physical activity levels — Baseline up to 6 months post therapy; Change in QOL measures — Baseline up to 6 months post therapy; Change in FCG-reported caregiving burden level and QOL scores — Baseline up to 6 months post therapy
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Cancer and ageing · 100%Title contains controlled topic terminology. Summary contains controlled topic terminology. Source terminology contains a controlled topic term. Title supplies ageing or longevity context.

Automated source check 100% · update recency 50%. These figures help sort records; they are not medical ratings.